Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Document for the general public

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Department of Reproductive Health and Research. Gender and reproductive rights: sexual health. World Health Organization. Available at: Accessed November 25, 2003.

  2. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.

  3. Althof SE . Quality of life and erectile dysfunction. Urology 2002; 59: 803–810.

    Article  PubMed  Google Scholar 

  4. Martin-Morales A et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166: 569–574, discussion 574–575.

    Article  CAS  PubMed  Google Scholar 

  5. Aytaç IA, McKinlay JB, Krane RJ . The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–56.

    Article  Google Scholar 

  6. Moncada I, Saenz de Tejada I . Vascular physiology of penile erection. In: Carson C, Kirby R, Goldstein I (eds). Textbook of Erectile Dysfunction. Isis Medical Media: Oxford, 1999, pp 51–57.

    Google Scholar 

  7. Lue TF . Erectile dysfunction. N Engl J Med 2000; 342: 1802–1813.

    Article  CAS  PubMed  Google Scholar 

  8. Moreland RB . Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 113–120.

    Article  CAS  PubMed  Google Scholar 

  9. Keene LC, Davies PH . Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev 1999; 18: 5–24.

    CAS  PubMed  Google Scholar 

  10. Burls A, Gold L, Clark W . Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. Br J Gen Pract 2001; 51: 1004–1012.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Fink HA et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002; 162: 1349–1360.

    Article  CAS  PubMed  Google Scholar 

  12. Brock GB et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168: 1332–1336.

    Article  CAS  PubMed  Google Scholar 

  13. Porst H et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001; 13: 192–199.

    Article  CAS  PubMed  Google Scholar 

  14. Hellstrom WJ et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763–771.

    CAS  PubMed  Google Scholar 

  15. Heaton JP . Apomorphine: an update of clinical trial results. Int J Impot Res 2000; 12(Suppl 4): S67–S73.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to I Moncada.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Moncada, I. Document for the general public. Int J Impot Res 16 (Suppl 2), S7–S9 (2004).

Download citation

  • Published:

  • Issue Date:

  • DOI:


  • treatment
  • sexual health


Quick links